Patients
| Country | Value | Year |
|---|---|---|
| France | 9.7 | 2023 |
| Germany | 11.1 | 2023 |
| Italy | 8.4 | 2023 |
| Russia | 23.3 | 2023 |
| Spain | 9.0 | 2023 |
| UK | 10.9 | 2023 |
Updated
Reviewed by Chandani Patel
Europe Intravascular Lithotripsy Market Industry Trends and Forecast to 2034: Segmented by (Application, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$844.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $159.2 Mn | — | — |
| 2025 (base) | $192.0 Mn | +$32.8 Mn | — |
| 2026 (forecast) | $231.5 Mn | +$39.5 Mn | +20.6% |
| 2027 (forecast) | $279.2 Mn | +$47.7 Mn | +45.4% |
| 2028 (forecast) | $336.8 Mn | +$57.5 Mn | +75.4% |
| 2029 (forecast) | $406.1 Mn | +$69.4 Mn | +111.5% |
| 2030 (forecast) | $489.8 Mn | +$83.7 Mn | +155.1% |
| 2031 (forecast) | $590.7 Mn | +$100.9 Mn | +207.7% |
| 2032 (forecast) | $712.4 Mn | +$121.7 Mn | +271% |
| 2033 (forecast) | $859.1 Mn | +$146.7 Mn | +347.5% |
| 2034 (forecast) | $1.04 Bn | +$177.0 Mn | +439.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $192.0 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.04 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 20.6% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Application, product and end user (see all) |
| Key players | Shockwave Medical (Johnson & Johnson), Boston Scientific Corporation, Abbott Laboratories, FastWave Medical, Amplitude Vascular (see all) |
| Regulator in Europe | EU MDRSource: European Commission, medical devices. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Intravascular lithotripsy uses sound waves inside an artery to crack hard calcium, making it easier to place stents.
Key segments of the intravascular Lithotripsy market include application (Coronary, Peripheral and Aortic Access) and product (Catheters and Generators).
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the intravascular Lithotripsy market.
Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the intravascular Lithotripsy market room to grow.
High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the intravascular Lithotripsy market.
The intravascular Lithotripsy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.[1] In the countries we cover here, medical devices are regulated by ANSM (France)[2], BfArM (Germany)[3], Ministry of Health (Italy)[4], Roszdravnadzor (Russia)[5], AEMPS (Spain)[6] and MHRA (UK)[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.[8]
[1] European Commission, medical devices. Checked 14 Nov 2026.
[2] ANSM, French medicines agency. Checked 14 Nov 2026.
[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.
[4] Italian Ministry of Health. Checked 14 Nov 2026.
[5] Roszdravnadzor. Checked 14 Nov 2026.
[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[8] European Commission, health technology assessment. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how intravascular Lithotripsy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.
What doctors and scientists are doing in Intravascular Lithotripsy right now, from free public sources.
| Country | Value | Year |
|---|---|---|
| France | 9.7 | 2023 |
| Germany | 11.1 | 2023 |
| Italy | 8.4 | 2023 |
| Russia | 23.3 | 2023 |
| Spain | 9.0 | 2023 |
| UK | 10.9 | 2023 |
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Europe · 2 shared keywords
Europe · 2 shared keywords
Europe · 1 shared keyword
Europe
Europe
Europe
Digital Health · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe
Healthcare Services · Europe